Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -34.12%42.9M | -36.39%13.81M | 5.13%5.71M | -93.32%1.2M | 11.19%22.17M | -68.27%65.11M | -81.29%21.7M | 110.44%5.43M | -87.55%18.04M | 651.65%19.94M |
Net income from continuing operations | -433.50%-1.32B | -35.69%-265.54M | -1,006.45%-455.26M | -8,592.18%-804.9M | 54,401.80%210.69M | 88.52%-246.49M | 55.00%-195.69M | 90.54%-41.15M | 98.86%-9.26M | 99.92%-388K |
Operating gains losses | 385.01%1.86B | 55.31%630.05M | 104,694.46%415.24M | 109,304.89%826.68M | 27.33%-15.86M | -0.48%382.69M | -6.82%405.67M | 96.56%-397K | 97.39%-757K | -112.41%-21.83M |
Depreciation and amortization | 24.55%120.12M | -5.78%29.16M | 21.56%29.74M | 51.63%31.46M | 46.71%29.77M | -57.34%96.45M | -55.24%30.94M | -62.29%24.47M | -58.41%20.75M | -51.91%20.29M |
Deferred tax | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non cash items | -61.54%-642.61M | 18.76%-97.2M | 14.51%-71M | -43.79%-139.59M | -241.56%-334.81M | -1.39%-397.82M | 59.72%-119.65M | -14.35%-83.06M | 65.88%-97.08M | -137.43%-98.03M |
Change In working capital | -116.55%-27.64M | -158.56%-306.62M | -26.16%66.47M | -11.15%79.06M | 25.23%133.45M | 112.43%166.98M | 42.03%-118.59M | 383.71%90.02M | -57.54%88.98M | 93.75%106.56M |
-Change in receivables | 188.58%659K | 4,734.26%5.22M | -691.33%-887K | -229.24%-3.57M | -229.27%-106K | 90.18%-744K | 143.72%108K | 102.73%150K | 63.95%-1.08M | -93.00%82K |
-Change in prepaid assets | 1.74%-20.39M | -142.85%-23.08M | 71.12%-2.97M | 647.13%11.64M | -619.88%-5.99M | -120.35%-20.75M | -108.26%-9.5M | 60.19%-10.27M | 91.80%-2.13M | -97.02%1.15M |
-Change in payables and accrued expense | -104.17%-10.39M | -77.34%46.12M | -95.78%1.22M | -3,039.19%-37.65M | -229.57%-20.09M | 467.32%249.29M | 393.64%203.52M | 183.37%28.99M | -96.32%1.28M | 470.14%15.5M |
-Change in other current assets | ---- | ---- | -17.66%67.93M | 14.08%110.16M | 54.73%152.81M | ---- | ---- | -21.09%82.5M | -61.26%96.56M | 3,381.00%98.76M |
-Change in other working capital | 104.09%2.49M | 88.59%-3.98M | 110.31%1.17M | 73.08%-1.52M | 176.39%6.82M | -1.78%-60.81M | -254.07%-34.89M | 42.89%-11.34M | 87.58%-5.65M | -157.75%-8.93M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -34.12%42.9M | -36.39%13.81M | 5.13%5.71M | -93.32%1.2M | 11.19%22.17M | -68.27%65.11M | -81.29%21.7M | 110.44%5.43M | -87.55%18.04M | 651.65%19.94M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -3,077.30%-95.19M | -1,320.25%-28.8M | -989.26%-31.24M | -414.38%-3.18M | -1,610.54%-31.97M | 99.49%-3M | 101.69%2.36M | 49.34%-2.87M | 99.65%-619K | 99.31%-1.87M |
Net PPE purchase and sale | -4,290.25%-94.96M | -1,322.18%-28.76M | -1,036.91%-31.17M | -1,234.04%-3.14M | -1,972.38%-31.89M | 99.64%-2.16M | 101.68%2.35M | 47.45%-2.74M | 99.87%-235K | 99.43%-1.54M |
Net intangibles purchase and sale | 72.27%-231K | -3,400.00%-231K | --0 | ---- | ---- | ---833K | 100.06%7K | ---126K | ---- | ---- |
Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other investing changes | ---- | ---- | ---66K | ---49K | 76.97%-76K | ---- | ---- | ---- | ---- | ---330K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -3,077.30%-95.19M | -1,320.25%-28.8M | -989.26%-31.24M | -414.38%-3.18M | -1,610.54%-31.97M | 99.49%-3M | 101.69%2.36M | 49.34%-2.87M | 99.65%-619K | 99.31%-1.87M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1,935.58%819.57M | 3,369.23%598.17M | 1,284.58%182.22M | -52.70%-15.19M | 5,424.49%54.36M | -114.58%-44.65M | -148.04%-18.3M | 65.89%-15.38M | -116.12%-9.95M | -100.41%-1.02M |
Net issuance payments of debt | 1,817.64%766.91M | 3,360.18%596.52M | 1,290.97%183.21M | -56.39%-15.56M | 368.76%2.74M | 68.91%-44.65M | -10.32%-18.3M | 71.70%-15.38M | 92.30%-9.95M | -101.81%-1.02M |
Net common stock issuance | --55M | --0 | --0 | --3.38M | --51.62M | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | --4.89M | --2.97M | --1.55M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net other financing activities | ---7.24M | ---1.32M | ---2.53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 1,935.58%819.57M | 3,369.23%598.17M | 1,284.58%182.22M | -52.70%-15.19M | 5,424.49%54.36M | -114.58%-44.65M | -148.04%-18.3M | 65.89%-15.38M | -116.12%-9.95M | -100.41%-1.02M |
Net cash flow | ||||||||||
Beginning cash position | 33.44%69.71M | 296.92%253.8M | 26.50%97.11M | 64.92%114.28M | 33.44%69.71M | -60.33%52.24M | 69.86%63.94M | -45.36%76.76M | -37.25%69.29M | -60.33%52.24M |
Current changes in cash | 4,292.19%767.27M | 10,014.08%583.18M | 1,322.57%156.7M | -329.93%-17.17M | 161.36%44.57M | 121.99%17.47M | -60.50%5.77M | 87.54%-12.82M | -75.15%7.47M | 180.26%17.05M |
End cash Position | 1,100.68%836.98M | 1,100.68%836.98M | 296.92%253.8M | 26.50%97.11M | 64.92%114.28M | 33.44%69.71M | 33.44%69.71M | 69.86%63.94M | -45.36%76.76M | -37.25%69.29M |
Free cash flow | -208.68%-52.3M | -250.86%-15.18M | -1,092.24%-25.46M | -111.30%-1.93M | -152.82%-9.72M | 112.14%48.12M | 141.52%10.07M | 104.48%2.57M | 140.46%17.09M | 106.75%18.4M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |